MG50 Activators
MG50 Activators are a set of chemical compounds that indirectly enhance the functional activity of MG50 through various signaling pathways, primarily involving cyclic nucleotide-mediated activation. Forskolin, by increasing intracellular cAMP levels, indirectly heightens MG50's functional role by activating PKA, which is known to phosphorylate targets that can lead to MG50 activation. IBMX and Rolipram act similarly by inhibiting phosphodiesterases, thus preventing cAMP degradation and increasing PKA activity, which subsequently can enhance MG50 activity through phosphorylation. On the other hand, compounds like Sildenafil, Vardenafil, Tadalafil, and Zaprinast selectively inhibit PDE5, leading to elevated cGMP levels. The resulting activation of PKG by these higher cGMP levels could then enhance MG50's activity, as PKG is capable of phosphorylating substrates that activate MG50.
Further contributing to the activation of MG50, PMA functions as a PKC activator, initiating a cascade of phosphorylation events that can lead to the activation of MG50. Phosphodiesterase inhibitors like Anagrelide, Cilostamide, and Milrinone work by inhibiting PDE3, thereby increasing cAMP levels and enhancing MG50's activity through PKA-mediated pathways. Lastly, EHNA, by inhibiting PDE2, leads to an accumulation of cAMP within the cell, activating PKA, and potentially promoting the phosphorylation and resultant activation of MG50. These chemical activators collectively utilize the intracellular signaling pathways governed by cyclic nucleotides to upregulate the activity of MG50, effectively leveraging the ubiquitous nature of these secondary messengers to modulate specific protein functions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. This elevation of cAMP can enhance the activity of MG50 by promoting cAMP-dependent protein kinase (PKA) phosphorylation events that are required for MG50 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes responsible for breaking down cAMP. By preventing cAMP degradation, IBMX indirectly increases PKA activity, which can phosphorylate and enhance the activity of MG50. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate substrates that lead to the activation of MG50 through PKC-mediated signaling pathways. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Similar to Sildenafil, Vardenafil is a PDE5 inhibitor that raises cGMP levels, potentially enhancing MG50 activity via PKG-dependent signaling pathways. | ||||||
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $180.00 | 13 | |
Tadalafil is another PDE5 inhibitor that can indirectly increase the activity of MG50 by raising intracellular cGMP levels and activating PKG signaling pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of PDE5 and PDE9, which leads to increased cGMP levels. Elevated cGMP can activate PKG, which in turn can enhance the activity of MG50 through phosphorylation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits PDE4, leading to an increase in cAMP levels. This boost in cAMP can enhance the activity of MG50 by promoting PKA-dependent signaling pathways. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide inhibits PDE3, increasing cAMP levels, which could enhance the activity of MG50 via PKA signaling pathways that are cAMP-dependent. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide is a selective inhibitor of PDE3, which increases cAMP levels and could potentially enhance MG50 activity through PKA-mediated phosphorylation processes. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone is a PDE3 inhibitor that raises intracellular cAMP, potentially enhancing MG50 activity via activation of PKA and subsequent phosphorylation. | ||||||